After passionately developing ParrotMD for nearly a year and a half, we are proud of how far we have come and optimistic about the future. Since the conception of the idea in Ghana, we have made countless prototypes, met with more people than we can count, received positive and negative feedback, and tested our prototypes in Guatemala. We still have a long journey ahead of us. The first step of that journey has just been made: ParrotMD beta testing has begun. 1,000 devices will be sent to clinics and hospitals throughout the US and around the world.
Our trip to Guatemala was an amazing experience- we saw firsthand a place where ParrotMD could have a major impact. Upon our return we realized that Guatemala is unique, but the problem we are aiming to solve exists elsewhere in the world. We received a lot of feedback that we should test ParrotMD in other cultures and environments. The problems and culture that are prominent in Guatemala differ greatly from those of Haiti or Malawi. There’s only one way to determine if ParrotMD will be as successful in those cultures, and that’s to test the idea there.
The problem of health illiteracy isn’t just a foreign one. The US Department of Education estimates that 32 million US adults cannot read above a 5th grade level; that’s about 10% of the population. This doesn’t include the millions of visually impaired people who cannot read their prescriptions. That is why we will also be testing ParrotMD in clinics here in the U.S.We will be working closely with clinics, hospitals, non-profits, and any organization that sees ParrotMD as a potential asset. Our goal is to receive feedback that shows quantitatively how effective ParrotMD is in improving patient compliance, where ParrotMD is most useful (be it location, patient or illness type), and how the devices can be implemented most effectively. It has been a great journey so far and we look forward to the challenges to come.